On the other hand, the molecular mutational status of main CRC oncogenes (KRAS, NRAS, BRAF, PIK3CA), associated with microsatellite instability (MSI) status, is now performed in clinical routine for the management of CRC. Here, KRAS is linked to colorectal carcinoma.